Skip to content

OnKure Therapeutics, Inc. OKUR Balance Sheet Statement

FY'25FY'24FY'23FY'22
$59.05M-46.7%$110.76M+271%$29.88M+49.9%$19.93M-84.0%
$60.84M-46.2%$113M+235%$33.77M-68.3%$106.35M-30.8%
$618K-39.7%$1.03M-28.4%$1.43M+216%$453K+114%
$62.12M-45.9%$114.91M+222%$35.73M-67.0%$108.18M-29.8%
$1.43M-51.7%$2.97M-13.1%$3.42M+80.5%$1.89M-6.4%
$5.92M-43.8%$10.53M+44.5%$7.29M+2.3%$7.12M+14.9%
$5.93M-46.4%$11.08M+42.9%$7.75M-5.6%$8.21M+20.5%
$0-100%$3K0.0%
-$214.24M-38.5%-$154.72M-51.6%-$102.05M+25.3%-$136.68M-61.3%
$56.18M-45.9%$103.83M+202%-$101.84M-87.1%-$54.42M-137%
$62.12M-45.9%$114.91M+222%$35.73M-67.0%$108.18M-29.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are OnKure Therapeutics, Inc.'s total assets?
OnKure Therapeutics, Inc. (OKUR) holds $198.7M in total assets, up 98.9% year over year.
How much debt does OnKure Therapeutics, Inc. have?
OnKure Therapeutics, Inc. carries $409.0K in total debt against $184.4M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does OnKure Therapeutics, Inc. have?
OnKure Therapeutics, Inc. holds $192.1M in cash and equivalents.
Can OnKure Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 13.78 — current assets exceed current liabilities.
Where does OnKure Therapeutics, Inc.'s balance sheet data come from?
Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.